Case number 1:19-cv-00203
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 8, 2023 | 212 | ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023) (3) |
| Dec 7, 2022 | 210 | TRANSFER ORDER. The Court ORDERS that the captioned case be transferred to and placed on the docket of the Honorable John P. Bailey, United States District Judge. Signed by Chief District Judge Thomas S Kleeh on 12/7/2022. (dk) (Entered: 12/07/2022) (1) |
| Nov 11, 2022 | 209 | REPORT to USPTO on the filing or determination of an action regarding re 208 Clerk's Judgment, 207 Memorandum & Opinion. (dk) (Entered: 11/11/2022) (1) |
| Nov 9, 2022 | 207 | VACATED PER ORDER 212 . MEMORANDUM OPINION AND ORDER FOLLOWING BENCH TRIAL. For the reasons discussed, Mylan has carried its burden of proving that the asserted claims are invalid pursuant to 35 U.S.C. § 112 for lack of enablement and lack of written description. The Court DIRECTS the Clerk to enter separate judgment orders in favor of the defendants, Mylan Pharmaceuticals Inc., and Kindeva Drug Delivery L.P., in Civil Action Numbers 1:18CV193 and 1:19CV203. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C, # 4 Attachment D) (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (Main Document) (65) |
| Nov 9, 2022 | 208 | VACATED PER ORDER 212 . CLERK'S JUDGMENT in favor of Mylan Pharmaceuticals Inc. against AstraZeneca AB, Astrazeneca Pharmaceuticals LP. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (1) |
| Nov 9, 2022 | 207 | VACATED PER ORDER 212 . MEMORANDUM OPINION AND ORDER FOLLOWING BENCH TRIAL. For the reasons discussed, Mylan has carried its burden of proving that the asserted claims are invalid pursuant to 35 U.S.C. § 112 for lack of enablement and lack of written description. The Court DIRECTS the Clerk to enter separate judgment orders in favor of the defendants, Mylan Pharmaceuticals Inc., and Kindeva Drug Delivery L.P., in Civil Action Numbers 1:18CV193 and 1:19CV203. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C, # 4 Attachment D) (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (Attachment A) (1) |
| Nov 9, 2022 | 207 | VACATED PER ORDER 212 . MEMORANDUM OPINION AND ORDER FOLLOWING BENCH TRIAL. For the reasons discussed, Mylan has carried its burden of proving that the asserted claims are invalid pursuant to 35 U.S.C. § 112 for lack of enablement and lack of written description. The Court DIRECTS the Clerk to enter separate judgment orders in favor of the defendants, Mylan Pharmaceuticals Inc., and Kindeva Drug Delivery L.P., in Civil Action Numbers 1:18CV193 and 1:19CV203. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C, # 4 Attachment D) (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (Attachment B) (1) |
| Nov 9, 2022 | 207 | VACATED PER ORDER 212 . MEMORANDUM OPINION AND ORDER FOLLOWING BENCH TRIAL. For the reasons discussed, Mylan has carried its burden of proving that the asserted claims are invalid pursuant to 35 U.S.C. § 112 for lack of enablement and lack of written description. The Court DIRECTS the Clerk to enter separate judgment orders in favor of the defendants, Mylan Pharmaceuticals Inc., and Kindeva Drug Delivery L.P., in Civil Action Numbers 1:18CV193 and 1:19CV203. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C, # 4 Attachment D) (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (Attachment C) (1) |
| Nov 9, 2022 | 207 | VACATED PER ORDER 212 . MEMORANDUM OPINION AND ORDER FOLLOWING BENCH TRIAL. For the reasons discussed, Mylan has carried its burden of proving that the asserted claims are invalid pursuant to 35 U.S.C. § 112 for lack of enablement and lack of written description. The Court DIRECTS the Clerk to enter separate judgment orders in favor of the defendants, Mylan Pharmaceuticals Inc., and Kindeva Drug Delivery L.P., in Civil Action Numbers 1:18CV193 and 1:19CV203. Signed by Senior Judge Irene M. Keeley on 11/9/2022. (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C, # 4 Attachment D) (dk) Modified on 3/8/2023 (hrc). (Entered: 11/09/2022) (Attachment D) (1) |
| May 31, 2022 | N/A | Set Motion, Evidentiary, R&R and Social Security Oral Arguments Deadlines/Hearings (0) Docket Text: Set/Reset Deadlines as to Oral Argument Hearing set for 6/22/2022 01:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. (dk) |
| May 17, 2022 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: Status Conference set for 5/18/2022 09:00 AM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. (dk) |
| May 16, 2022 | 205 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 5/13/2022 before Judge Keeley. (ck) |
| May 16, 2022 | 206 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by AstraZeneca AB for proceedings held on 5/13/2022 before Judge Keeley. (ck) |
| Apr 12, 2022 | 194 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 4/8/2022 before Judge Keeley. (ck) |
| Apr 11, 2022 | 192 | Transcript (19) Docket Text: TRANSCRIPT of status conference held on 4/8/2022, before Judge Keeley. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 5/2/2022. Redacted Transcript Deadline set for 5/12/2022. Release of Transcript Restriction set for 7/11/2022. (ck) |
| Apr 11, 2022 | 193 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by AstraZeneca AB for proceedings held on 4/8/2022 before Judge Keeley. (ck) |
| Apr 7, 2022 | N/A | Set Deadlines/Hearings (0) Docket Text: Set Deadlines/Hearings: Status Conference set for 4/8/2022 01:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. (dk) |
| Mar 29, 2022 | 190 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 3/22/2022 before Judge Keeley. (ck) |
| Mar 29, 2022 | 191 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by AstraZeneca AB for proceedings held on 3/22/2022 before Judge Keeley. (ck) |
| Mar 9, 2022 | 201 | Other Document (1) Docket Text: MANDATE of USCA for the Federal Circuit as to [195] Notice of Appeal filed by Mylan Pharmaceuticals Inc. Case reopened. (dk) |
| Mar 2, 2022 | 200 | Other Document (2) Docket Text: PER CURIUM ORDER of USCA for the FEDERAL CIRCUIT re [195] Notice of Appeal filed by Mylan Pharmaceuticals Inc. FEDERAL CIRCUIT DECISION: Petition for panel rehearing is DENIED. Petition for rehearing en banc is DENIED. The mandate of the court will issue March 9, 2022. (dk) |
| Feb 7, 2022 | 186 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 1/31/2022 before Judge Keeley. (ck) |
| Feb 7, 2022 | 187 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by AstraZeneca AB for proceedings held on 1/31/2022 before Judge Keeley. (ck) |
| Dec 8, 2021 | 198 | Other Document (30) Docket Text: OPINION of USCA for the FEDERAL CIRCUIT as to [195] Notice of Appeal filed by Mylan Pharmaceuticals Inc. THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED-IN-PART, VACATED-IN-PART, AND REMANDED. (dk) |
| Dec 8, 2021 | 199 | Other Document (1) Docket Text: USCA for the FEDERAL CIRCUIT JUDGMENT as to [195] Notice of Appeal filed by Mylan Pharmaceuticals Inc. THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED-IN-PART, VACATED-IN-PART, AND REMANDED. (dk) |
| Jun 28, 2021 | 11 | Motion for Leave to Appear (2) |
| Jun 28, 2021 | 19 | Motion to Dismiss (2) |
| Jun 28, 2021 | 32 | Motion to Transfer Case (1) |
| Jun 28, 2021 | 38 | Motion for Leave to Appear (2) |
| Jun 28, 2021 | 110 | Motion for Leave to Appear (2) |
| Jun 28, 2021 | 144 | Motion for Leave to Appear (2) |
| Jun 28, 2021 | 145 | Motion to Compel (2) |
| Mar 12, 2021 | 197 | Other Document (4) Docket Text: USCA NOTICE OF APPELLATE CASE OPENING re [195] Notice of Appeal filed by Mylan Pharmaceuticals Inc. Federal Circuit USCA Case Number: 2021-1729. (dk) |
| Mar 10, 2021 | 196 | Main Document (1) Docket Text: Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals Federal Circuit re [195] Notice of Appeal. (Attachments: # (1) Attorney List, # (2) Notice of appeal, # (3) Memo Opinion and Order, # (4) Clerk's Judgment, # (5) Amended Judgment, # (6) Public Docket Sheet)(dk) |
| Mar 10, 2021 | 196 | Attorney List (20) |
| Mar 10, 2021 | 196 | Notice of appeal (3) |
| Mar 10, 2021 | 196 | Memo Opinion and Order (48) |
| Mar 10, 2021 | 196 | Clerk's Judgment (1) |
| Mar 10, 2021 | 196 | Amended Judgment (2) |
| Mar 10, 2021 | 196 | Public Docket Sheet (61) |
| Mar 9, 2021 | 195 | Other Document (3) Docket Text: NOTICE OF APPEAL as to [181] Memorandum & Opinion, [182] Clerk's Judgment filed by Mylan Pharmaceuticals Inc. [183] Judgment filed by Mylan Pharmaceuticals, Inc. Filing fee $; 505, receipt number 0424-3218687. (dk) |
| Mar 8, 2021 | 183 | Judgment (2) Docket Text:AMENDED FINAL JUDGMENT in favor of Plaintiffs against Defendants Signed by Senior Judge Irene M. Keeley on 3/8/2021. (copy counsel of record) (jmm) |
| Mar 2, 2021 | 181 | Memorandum & Opinion (45) |
| Mar 2, 2021 | 181 | Attachment A (1) |
| Mar 2, 2021 | 181 | Attachment B (1) |
| Mar 2, 2021 | 181 | Attachment C (1) |
| Mar 2, 2021 | 182 | Clerk's Judgment (1) Docket Text: CLERK'S JUDGMENT in favor of AstraZeneca AB, Astrazeneca Pharmaceuticals LP against Mylan Pharmaceuticals Inc. Signed by Senior Judge Irene M. Keeley on 3/2/2021. (copy counsel of record) (jmm) |
| Mar 2, 2021 | 181 | Main Document (45) Docket Text:MEMORANDUM OPINION AND ORDER MAKING FINDINGS OF FACT AND GRANTING JUDGMENT IN FAVOR OF THE PLAINTIFFS, ASTRAZENECA AB AND ASTRAZENECA PHARMACEUTICALS LP. The Clerk is directed to enter separate judgment orders in favor of Plaintiffs, AstraZeneca AB and AstraZeneca Pharmaceuticals LP, in Civil Action Nos. 1:18cv193 and 1:19cv203. Signed by Senior Judge Irene M. Keeley on 3/2/2021. (copy counsel of record)(jmm) (Additional attachment(s) added on 3/2/2021: # (1) Attachment A, # (2) Attachment B, # (3) Attachment C) NEF regenerated (jmm). |
| Feb 2, 2021 | 180 | Corporate Disclosure Statement (3) Docket Text: Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc... (O'Brien, William) |
| Jul 31, 2020 | N/A | Set/Reset Hearings (0) |
| Jul 29, 2020 | N/A | Set/Reset Hearings (0) |
| Jul 23, 2020 | N/A | Set/Reset Hearings (0) |
| Jul 6, 2020 | N/A | Set/Reset Hearings (0) |
| Jan 14, 2020 | 179 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Adam S Ennis on behalf of 3M Company, Mylan Pharmaceuticals Inc. (Ennis, Adam) |
| Jan 9, 2020 | 178 | Stipulation (3) Docket Text: STIPULATION Regarding Expert Discovery Deadlines by 3M Company, Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Nov 12, 2019 | 176 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of 3M Company (Copland, Gordon) |
| Nov 12, 2019 | 177 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by John D. Pizzo on behalf of 3M Company, Mylan Pharmaceuticals Inc. (Pizzo, John) |
| Nov 7, 2019 | 173 | Order (2) Docket Text: ORDER CONSOLIDATING CASES. Civil Action No. 1:18-cv-193 will serve as the lead case where all filings should be docketed. Signed by Senior Judge Irene M. Keeley on 11/7/19. (mh) |
| Nov 7, 2019 | 175 | Order (2) Docket Text: ORDER WAIVING PRO HAC VICE FILINGS AND FEES. The parties will not be required to file pro hac vice motions, or pay pro hac vice fees, for any outside counsel who have previously appeared and been admitted pro hac vice in Civil Action No. 1:18cv193. Signed by Senior Judge Irene M. Keeley on 11/7/2019. (dk) |
| Nov 6, 2019 | 172 | Status Report (1) |
| Nov 6, 2019 | 172 | Text of Proposed Order Proposed Order (1) |
| Nov 6, 2019 | 172 | Main Document (1) Docket Text: STATUS REPORT Joint Status Report by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Attachments: # (1) Text of Proposed Order Proposed Order)(Companion, James) |
| Nov 5, 2019 | 170 | Order of Recusal (1) Docket Text: ORDER OF RECUSAL. The Court ORDERS that the above-styled civil action be transferred to and placed on the docket of the Honorable Irene M. Keeley, United States District Judge. Case reassigned to Senior Judge Irene M. Keeley for all further proceedings. Signed by District Judge Thomas S. Kleeh on 11/5/2019. (dk) |
| Nov 5, 2019 | 171 | Order (1) Docket Text: ORDER SCHEDULING STATUS CONFERENCE for 11/7/2019 09:00 AM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. The Court DIRECTS lead counsel for Mylan to arrange the conference call and provide dial-in information to all parties and the Court, by email to candace_levitsky@wvnd.uscourts.gov, no later than Wednesday, November 6, 2019. The Court further DIRECTS the parties to file a joint status report by Wednesday, November 6, 2019, indicating whether the parties will agree to consolidate these cases for all purposes. Signed by Senior Judge Irene M. Keeley on 11/5/2019. (dk) |
| Nov 4, 2019 | 167 | Case Transferred In - District Transfer (22) |
| Nov 4, 2019 | 167 | *Restricted* (22) |
| Nov 4, 2019 | 168 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) |
| Nov 4, 2019 | 169 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION as to Attorneys Kelly, Han, Silver, Behrens, Stole, Rubman, White, Anstaett, Grebb, Chajon, and Bloodworth. (dk) |
| Nov 4, 2019 | 167 | Main Document Public Docket Sheet (22) Docket Text: Case transferred in from District of Delaware; Case Number 1:18-cv-01562. (dk) |
| Nov 1, 2019 | 165 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Nov 1, 2019 | 166 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) and (2) Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Supplemental Objections and Responses to Plaintiffs' First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Oct 31, 2019 | 164 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Oct 22, 2019 | 162 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Plaintiffs' Motion to Compel by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re [145] MOTION to Compel , [146] Letter (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 22, 2019 | 163 | Redacted Document (4) Docket Text: REDACTED VERSION of [146] Letter by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 156 | Memorandum & Opinion (26) Docket Text: MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 10/18/2019. (nmf) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 157 | Order on Motion to Transfer Case (2) Docket Text: ORDER granting [32] Motion to Transfer Case; finding as moot [32] Motion to Dismiss ; denying [19] Motion to Dismiss. Signed by Judge Colm F. Connolly on 10/18/2019. (nmf) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 158 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendant 3M Company's Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by 3M Company.(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 159 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS OBJECTIONS AND RESPONSES TO DEFENDANTS MYLAN PHARMACEUTICALS, INC., 3M COMPANY, TEVA PHARMACEUTICALS USA, INC., AND CATALENT PHARMA SOLUTIONS LLCS FIRST NOTICE OF DEPOSITION OF ASTRAZENECA AB AND ASTRAZENECA PHARMACEUTICALS LP PURSUANT TO FED. R. CIV. P. 30(b)(6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 160 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum directed to Morgan, Lewis & Bockius LLP and a subpoena ad testificandum directed to Gregory T. Lowen filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)[Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2019 | 161 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding transfer of case and further redactions - re [152] Letter. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Oct 17, 2019 | N/A | Staff Note - AO85 (0) Docket Text: The Discovery Conference originally set for today, 10/17/2019, at 3:00 p.m. is cancelled per counsel as it is no longer needed. (nmf) [Transferred from Delaware on 11/4/2019.] |
| Oct 17, 2019 | 153 | Redacted Document (14) Docket Text: REDACTED VERSION of [114] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 17, 2019 | 154 | Redacted Document (16) Docket Text: REDACTED VERSION of [116] Notice (Other) by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 17, 2019 | 155 | Redacted Document (16) Docket Text: REDACTED VERSION of [117] Notice (Other) by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 16, 2019 | 149 | Redacted Document (4) |
| Oct 16, 2019 | 149 | Exhibit A-C (16) |
| Oct 16, 2019 | 150 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Response to Defendants' Invalidity Contentions filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 16, 2019 | 151 | Redacted Document (30) Docket Text: REDACTED VERSION of [39] Answering Brief in Opposition, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 16, 2019 | 152 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Further redactions to D.I. 41 - re [41] Declaration. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Oct 16, 2019 | 149 | Main Document (4) Docket Text: REDACTED VERSION of [147] Letter, to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Response to Plaintiffs' letter of October 14, 2019 regarding discovery disputes by 3M Company, Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A-C)(Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Oct 15, 2019 | N/A | Order on Motion for Leave to Appear (0) Docket Text: SO ORDERED, re (144 in 1:18-cv-01562-CFC, 98 in 1:18-cv-01685-CFC) MOTION for Pro Hac Vice Appearance of Attorney Megan P. Keane filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Colm F. Connolly on 10/15/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(fms) [Transferred from Delaware on 11/4/2019.] |
| Oct 15, 2019 | 148 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Noninfringement Contentions filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 14, 2019 | N/A | Calendar Entry (0) Docket Text: CORRECTING ENTRY: DI # 41 was placed back under seal by the Intake Supervisor pursuant to e-mail received from Counsel per Mylan. (rwc) [Transferred from Delaware on 11/4/2019.] |
| Oct 14, 2019 | 145 | Text of Proposed Order (1) |
| Oct 14, 2019 | 145 | Averment of Counsel (1) |
| Oct 14, 2019 | 145 | Main Document (2) Docket Text: MOTION to Compel - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Text of Proposed Order, # (2) Averment of Counsel)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2019 | N/A | Oral Order (0) |
| Oct 11, 2019 | N/A | Oral Order (0) |
| Oct 11, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed the redacted version of D.I. [41], docketed as D.I. [55]. The Court finds that good cause does not exist to redact many of the proposed redactions. The Court will nonetheless allow the parties to propose more limited redactions of D.I.[41] and will entertain argument that good cause exists to make such redactions if supported by sworn declaration(s) from a person and/or persons employed by the party that seeks the redaction(s) in question. Ordered by Judge Colm F. Connolly on 10/11/2019. (nmf) [Transferred from Delaware on 11/4/2019.] |
| Oct 10, 2019 | N/A | Oral Argument Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Oral Argument held on 10/10/2019. (Court Reporter V. Gunning.) (nmf) [Transferred from Delaware on 11/4/2019.] |
| Oct 10, 2019 | 144 | Certification for Megan P. Keane (1) |
| Oct 10, 2019 | 144 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Megan P. Keane - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Megan P. Keane)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 9, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Oct 9, 2019 | 141 | Claim (30) Docket Text: Joint CLAIM CONSTRUCTION OPENING BRIEF filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 9, 2019 | 142 | Attorney Appointed (8) |
| Oct 9, 2019 | 142 | Exhibit J1 (28) |
| Oct 9, 2019 | 142 | Exhibits P1 - P11DD (450) |
| Oct 9, 2019 | 142 | Exhibits D1 - D4 (323) |
| Oct 9, 2019 | 143 | Notice (Other) (2) Docket Text: Joint NOTICE of Service of Case Compendium In Support of Joint Claim Construction Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief (Joyce, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 9, 2019 | 142 | Main Document (8) Docket Text: Joint APPENDIX re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit J1, # (2) Exhibits P1 - P11DD, # (3) Exhibits D1 - D4)(Joyce, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 132 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum on Fish & Richardson PC and a subpoena ad testificandum on Janis K. Fraser filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 133 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Annette Purrington on October 29, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 134 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Jack Rasmussen on October 25, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 135 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Kim Kriesel on October 22, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 136 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Martin Wilson on October 23, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 137 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Rupi Pannu on October 21, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 138 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Stephen Stein on October 31, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 139 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Wayne Talton on October 24, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 8, 2019 | 140 | Motion for Extension of Time to File (2) Docket Text: Joint STIPULATION TO EXTEND TIME the deadline for the Parties to submit their Joint Claim Construction Brief to Wednesday, October 9, 2019 (from Tuesday, October 8, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Oct 7, 2019 | 131 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Markman Brief filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | N/A | Calendar Entry (0) |
| Oct 4, 2019 | 121 | Letter (2) |
| Oct 4, 2019 | 121 | Exhibit A (7) |
| Oct 4, 2019 | 121 | Exhibit B (6) |
| Oct 4, 2019 | 122 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Domenick Fanelli on October 15. 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 123 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Nayna Govind on October 28, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 124 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Darren Hodson on October 24, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 125 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Andy Ludzik on October 21, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 126 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Maria Marlow on November 1, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 127 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Jorgen Rasmussen on October 30, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 128 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Gary Rowles on October 18, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 129 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Jonas Sibomana on October 17, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 130 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Frank Trudo on October 16, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 4, 2019 | 121 | Main Document (2) Docket Text: Letter to Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Supplemental Authority. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Oct 2, 2019 | 118 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals, Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs First Notice of Deposition of AstraZeneca AB and AstraZeneca Pharmaceuticals LP Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Oct 2, 2019 | 119 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories (Nos. 1-3) and Second Set of Requests for Production of Documents and Things (Nos. 123-129) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 2, 2019 | 120 | Response to Discovery (3) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions, LLC's Third Set of Common Interrogatories to Plaintiffs (Nos. 12-18) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 1, 2019 | 115 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 11) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Sep 28, 2019 | N/A | Calendar Entry (0) |
| Sep 23, 2019 | 113 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Reply Markman Brief and (2) Reply Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Sep 20, 2019 | N/A | Oral Order (0) |
| Sep 20, 2019 | N/A | Oral Order (0) |
| Sep 19, 2019 | N/A | Add and Terminate Attorneys (0) Docket Text: Pro Hac Vice Attorney Brandon M. White for 3M Company and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) [Transferred from Delaware on 11/4/2019.] |
| Sep 17, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Sep 17, 2019 | N/A | Add and Terminate Attorneys (0) |
| Sep 17, 2019 | 110 | Certification for Einar Stole (1) |
| Sep 17, 2019 | 111 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Dr. Anthony J. Cutie on September 18, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Sep 17, 2019 | 112 | Response to Discovery (2) Docket Text: NOTICE to Take Deposition of Robert Boyd on September 19, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Sep 17, 2019 | 110 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Einar Stole - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Einar Stole)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Sep 16, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Sep 16, 2019 | 108 | Motion for Leave to Appear (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Sep 16, 2019 | 109 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Michael A. Chajon on behalf of 3M Company, Mylan Pharmaceuticals Inc. (Chajon, Michael) [Transferred from Delaware on 11/4/2019.] |
| Sep 10, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Sep 9, 2019 | 107 | Response to Discovery (3) Docket Text: NOTICE OF SERVICE of (1)Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs Answering Claim Construction Brief; (2) Declaration of Dr. Anthony J. Cutie in Support of Defendants Answering Claim Construction Brief; and (3) Declaration of Robert Boyd in Support of Defendants Answering Claim Construction Brief filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Sep 6, 2019 | N/A | Set/Reset Hearings (0) |
| Sep 6, 2019 | 106 | Motion for Extension of Time to File (3) Docket Text: STIPULATION TO EXTEND TIME (1) Service of Defendants Answering Claim Construction Brief is hereby extended to Monday, September 9, 2019 (from Friday, September 6); (2) Service of Plaintiffs Reply Claim Construction Brief is hereby extended to Monday, September 23 (from Tuesday, September 17); (3) Service of Defendants Sur-Reply Claim Construction Brief is hereby extended to Thursday, October 3 (from Friday, September 27); and (4) the deadline to file the Joint Claim Construction Brief is hereby extended to Tuesday, October 8 (from Wednesday, October 2) to - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Sep 3, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Aug 30, 2019 | 105 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for Joinder of Other Parties and Amendment of Pleadings to September 6, 2019 - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Aug 27, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Aug 26, 2019 | 104 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for substantial completion of document production to September 6, 2019 - filed by Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Aug 20, 2019 | 103 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Opening Markman Brief; and (2) Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Aug 14, 2019 | 102 | Order on Motion for Leave to Appear (7) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 4/22/2020 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 8/14/19. (cak)[Transferred from Delaware on 11/4/2019.] |
| Aug 13, 2019 | 100 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Responsive Letter - re [94] Order,,,. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Aug 13, 2019 | 101 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding effect, if any, of merger between Mylan and Upjohn - re [94] Order,,,. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Aug 8, 2019 | N/A | Staff Note - AO85 (0) |
| Aug 7, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Aug 5, 2019 | 96 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Default Word Limits for Markman Briefs - re (66 in 1:18-cv-01562-CFC) Scheduling Order,,. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Aug 5, 2019 | 97 | MEMORANDUM (20) |
| Aug 5, 2019 | 97 | Exhibit A-E (108) |
| Aug 5, 2019 | 98 | Public Motion for Misc Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Aug 5, 2019 | 99 | Public Motion for Misc Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Aug 5, 2019 | 97 | Main Document (20) Docket Text: CLAIM Construction Chart by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A-E)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Aug 2, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Aug 2, 2019 | 94 | Order (3) Docket Text: ORDER, On or before August 13, 2019, the parties shall each file a three-page letter (in 14-point, Times New Roman font) informing the Court what effect, if any, the announced merger has on Mylan's pending motion as well as on this litigation, including but not limited to Mylan's status as a West Virginia corporation and its status as the holder of the relevant AND As in this case. Additionally, given the Court's present inclination to transfer the case against Mylan to the Northern District of West Virginia as well as its understanding that Defendant 3M Company consents to transfer to the Northern District, see D.I. 33 at 3, Plaintiffs AstraZeneca AB and AstraZeneca Pharmaceuticals LP, in their letter, shall inform the Court whether they consent to the transfer of the claims against 3M Company to the Northern District. Signed by Judge Colm F. Connolly on 8/2/2019. (nmf) [Transferred from Delaware on 11/4/2019.] |
| Aug 2, 2019 | 95 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to: (1) submit the Joint Claim Construction Chart and (2) submit their position regarding word limits for Claim Construction briefing to Monday, August 5, 2019 (from Friday, August 2, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jul 31, 2019 | 93 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME to Submit the Joint Claim Construction Chart to August 2, 2019 - filed by 3M Company, Mylan Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jul 29, 2019 | 91 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS IDENTIFICATION OF INTRINSIC EVIDENCE IN OPPOSITION TO DEFENDANTS PROPOSED CONSTRUCTIONS filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jul 29, 2019 | 92 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's list of term(s)/phrase(s) in issue and list of the rebuttal evidence on which Defendants intend to rely filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jul 25, 2019 | 88 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Constructions and Identification of Intrinsic Evidentiary Support filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jul 25, 2019 | 89 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Mylan Pharmaceuticals Inc.'s First Amended Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to Mylan (Nos. 1-62) and (2) Defendant 3M Company's First Amended Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to 3M (Nos. 1-60) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jul 25, 2019 | 90 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's proposed constructions and identification of intrinsic evidentiary support filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Jul 22, 2019 | 87 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel)[Transferred from Delaware on 11/4/2019.] |
| Jul 19, 2019 | 85 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs List of Proposed Claim Terms for Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jul 19, 2019 | 86 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's proposed terms for construction filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jul 16, 2019 | 84 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's Invalidity Contentions and the Document Production Accompanying Invalidity Contentions filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Jul 1, 2019 | 83 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of PLAINTIFFS OBJECTIONS AND RESPONSES TO DEFENDANTS FIRST SET OF REQUESTS FOR THE PRODUCTION OF DOCUMENTS AND THINGS (NOS. l122) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel)[Transferred from Delaware on 11/4/2019.] |
| Jun 26, 2019 | 82 | Paperless Order (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 8/5/2019 at 11:30 AM before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 6/26/19. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) [Transferred from Delaware on 11/4/2019.] |
| Jun 24, 2019 | 81 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) [Transferred from Delaware on 11/4/2019.] |
| Jun 21, 2019 | 80 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jun 19, 2019 | 79 | Protective Order (23) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 6/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(fms) [Transferred from Delaware on 11/4/2019.] |
| Jun 17, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Jun 17, 2019 | 78 | Civil Cover Sheet (23) Docket Text: PROPOSED ORDER Stipulated Protective Order by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jun 14, 2019 | 77 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to Submit Proposed Protective Order to June 17, 2019 - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jun 13, 2019 | 76 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's Objections and Responses to Plaintiffs' First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jun 11, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Jun 11, 2019 | 74 | Redacted Document (30) Docket Text: REDACTED VERSION of [71] Amended Complaint, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jun 11, 2019 | 75 | Redacted Document (30) Docket Text: REDACTED VERSION of [67] Stipulation by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jun 10, 2019 | 73 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Submit Proposed Protective Order to Friday, June 14, 2019 (from Monday June 10, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jun 4, 2019 | N/A | Calendar Entry (0) |
| Jun 4, 2019 | 72 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Asserted Claims and Infringement Contentions Against Defendants filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| May 31, 2019 | N/A | Other Document (0) Docket Text: NOTICE TO COUNSEL RE: SECOND AMENDED COMPLAINT AND PATENT REPORT: Counsel should file the Second Amended Complaint electronically with the court as the attachment to the stipulation appears to be missing exhibits. Also, please note that if patents are being added to this case through the SECOND AMENDED COMPLAINT referenced in D.I. [67] and [68], the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) [Transferred from Delaware on 11/4/2019.] |
| May 31, 2019 | 69 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-122) filed by 3M Company, Mylan Pharmaceuticals Inc..(Rawnsley, Jason) [Transferred from Delaware on 11/4/2019.] |
| May 31, 2019 | 70 | Report Re: Patent/Trademark (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328 ;8,143,239 ;8,575,137 ;7,967,011 ;10,166,247 . (Silver, Daniel) Modified on 6/4/2019 (fms). [Transferred from Delaware on 11/4/2019.] |
| May 21, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) [Transferred from Delaware on 11/4/2019.] |
| May 20, 2019 | 66 | Set Scheduling Order Deadlines (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/30/2019. Amended Pleadings due by 8/30/2019. Fact Discovery completed by 11/1/2019. Joint Claim Construction Brief due by 10/2/2019. A Markman Hearing is set for 12/4/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 6/2/2020 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/15/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/20/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) [Transferred from Delaware on 11/4/2019.] |
| May 17, 2019 | 64 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs AstraZeneca AB and AstraZeneca Pharmaceuticals LPs Initial Disclosures Pursuant to Rule 26(a)(1); (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; and (3) Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of The Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| May 17, 2019 | 65 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s and 3M Company's Discovery Disclosures and Defendant Mylan Pharmaceuticals Inc.'s and 3M Company's Objections and Responses to Plaintiff's First Set of Common Interrogatories (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| May 15, 2019 | 63 | Civil Cover Sheet (18) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| May 14, 2019 | 62 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Plaintiffs First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| May 10, 2019 | 61 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to Mylan (Nos. 1-62) and Defendant 3M Company's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to 3M (Nos. 1-60) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Apr 17, 2019 | 60 | Response to Discovery (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Apr 15, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 4/15/2019. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the Court. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) [Transferred from Delaware on 11/4/2019.] |
| Apr 12, 2019 | 59 | Civil Cover Sheet (14) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Apr 10, 2019 | 58 | Response to Discovery (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests for Production of Documents and Things to Mylan (Nos. 1-62), (2) Plaintiffs First Set of Requests for Production of Documents and Things to 3M (Nos. 1-60) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Apr 9, 2019 | 57 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq.. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Apr 2, 2019 | 56 | Redacted Document (23) Docket Text: REDACTED VERSION of [49] Reply Brief, by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Mar 28, 2019 | 53 | Redacted Document (30) Docket Text: REDACTED VERSION of [39] Answering Brief in Opposition, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Mar 28, 2019 | 54 | Redacted Document (4) Docket Text: REDACTED VERSION of [40] Declaration by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Mar 28, 2019 | 55 | Redacted Document (10) Docket Text: REDACTED VERSION of [41] Declaration by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Mar 26, 2019 | 52 | Other Document (1) Docket Text: REQUEST for Oral Argument by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party . (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Mar 22, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Mar 21, 2019 | 51 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for the Plaintiffs to Submit Redacted Versions of (1) Plaintiffs' Consolidated Opposition to the Mylan Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue and 3M's Motion to Dismiss or Transfer Venue, (2) Declaration of Domenick Fanelli; and (3) Declaration of Anna Q. Han to Thursday, March 28, 2019 (from Thursday, March 21, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel)[Transferred from Delaware on 11/4/2019.] |
| Mar 20, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Mar 19, 2019 | 48 | Motion for Leave to Appear (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David L. Anstaett - filed by 3M Company. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Mar 19, 2019 | 49 | Response to Motion (23) Docket Text: REPLY BRIEF re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party filed by 3M Company, Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) Modified on 10/11/2019 (nmf). [Transferred from Delaware on 11/4/2019.] |
| Mar 19, 2019 | 50 | Other Document (2) |
| Mar 19, 2019 | 50 | Exhibit 1-4 (80) |
| Mar 19, 2019 | 50 | Main Document (2) Docket Text: DECLARATION re [49] Reply Brief, (Declaration of Emily J. Greb) by 3M Company, Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-4)(Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Mar 18, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Mar 18, 2019 | N/A | Add and Terminate Attorneys (0) |
| Mar 14, 2019 | 46 | Order on Motion for Leave to Appear (3) Docket Text: SO ORDERED, re [45] Stipulation of Dismissal filed by Mylan N.V., Mylan Laboratories Limited, Mylan Inc., Party Mylan N.V., Mylan Inc. and Mylan Laboratories Limited terminated. Signed by Judge Colm F. Connolly on 3/13/2019. (fms) Modified on 3/14/2019 (fms). [Transferred from Delaware on 11/4/2019.] |
| Mar 14, 2019 | 47 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME for the Plaintiffs to Submit Redacted Versions of (1) Plaintiffs' Consolidated Opposition to the Mylan Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue and 3M's Motion to Dismiss or Transfer Venue, (2) Declaration of Domenick Fanelli; and (3) Declaration of Anna Q. Han to Thursday, March 21, 2019 (from Thursday, March 14, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel)[Transferred from Delaware on 11/4/2019.] |
| Mar 13, 2019 | 45 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Regarding Dismissal of Certain Defendants by Mylan Inc., Mylan Laboratories Limited, Mylan N.V.. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Mar 8, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Mar 8, 2019 | 44 | Set Scheduling Order Deadlines (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/15/2019 at 03:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/8/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf)[Transferred from Delaware on 11/4/2019.] |
| Mar 7, 2019 | 43 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME to file redactions to DI. 39, 40 and 41 to March 14, 2019 - filed by 3M Company, Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Mar 5, 2019 | N/A | Add and Terminate Attorneys (0) |
| Mar 5, 2019 | 42 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Proposed Scheduling Order - re (37 in 1:18-cv-01562-CFC, 37 in 1:18-cv-01562-CFC, 19 in 1:18-cv-01685-CFC, 19 in 1:18-cv-01685-CFC) Order,, Set Deadlines,. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Feb 28, 2019 | 40 | Other Document (3) |
| Feb 28, 2019 | 40 | Certificate of Service (1) |
| Feb 28, 2019 | 40 | Main Document (3) Docket Text: DECLARATION re [39] Answering Brief in Opposition, of Domenick Fanelli by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certificate of Service)(Silver, Daniel) Modified on 10/11/2019 (nmf).[Transferred from Delaware on 11/4/2019.] |
| Feb 22, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Feb 21, 2019 | 38 | Certifications for Douglas A. Behrens (1) |
| Feb 21, 2019 | 38 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas A. Behrens - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certifications for Douglas A. Behrens)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Feb 19, 2019 | 37 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before March 5, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/5/2019.) Signed by Judge Colm F. Connolly on 2/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf)[Transferred from Delaware on 11/4/2019.] |
| Feb 4, 2019 | 36 | Order on Motion for Leave to Appear (2) Docket Text: SO ORDERED, re [35] Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Set Briefing Schedule: re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party . (Answering Brief due 2/28/2019., Reply Brief due 3/19/2019.). See Stipulation for further details. Signed by Judge Colm F. Connolly on 2/4/2019. (fms)[Transferred from Delaware on 11/4/2019.] |
| Feb 1, 2019 | 35 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Briefing on Motions to Dismiss re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 24, 2019 | 32 | Text of Proposed Order (1) |
| Jan 24, 2019 | 33 | Memorandum in Opposition to Motion (17) Docket Text: OPENING BRIEF in Support re [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party filed by 3M Company.Answering Brief/Response due date per Local Rules is 2/7/2019. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Jan 24, 2019 | 34 | Corporate Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by 3M Company. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Jan 24, 2019 | 32 | Main Document (1) Docket Text: MOTION to Transfer Case to Northern District of West Virginia, MOTION to Dismiss for Failure to Join a Party - filed by 3M Company. (Attachments: # (1) Text of Proposed Order)(Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Jan 23, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Jan 22, 2019 | N/A | Add and Terminate Attorneys (0) |
| Jan 18, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Jan 18, 2019 | 30 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME Plaintiffs' Deadline to Submit an Answering Brief to Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue to Thursday, February 21, 2019 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jan 18, 2019 | 31 | Motion for Leave to Appear (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth and Emily J. Greb - filed by 3M Company. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 17, 2019 | 27 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Alexandra M. Ewing on behalf of 3M Company (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 17, 2019 | 28 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of 3M Company (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Jan 17, 2019 | 29 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jason James Rawnsley on behalf of 3M Company (Rawnsley, Jason) [Transferred from Delaware on 11/4/2019.] |
| Jan 15, 2019 | 25 | Redacted Document (23) Docket Text: REDACTED VERSION of [20] Opening Brief in Support, by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 15, 2019 | 26 | Redacted Document (7) |
| Jan 15, 2019 | 26 | Exhibit 1-3 (211) |
| Jan 15, 2019 | 26 | Main Document (7) Docket Text: REDACTED VERSION of [21] Declaration, by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-3)(Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 14, 2019 | 24 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Ewing (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Jan 10, 2019 | N/A | Add and Terminate Attorneys (0) |
| Jan 8, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Jan 8, 2019 | 23 | Motion for Leave to Appear (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth, David L. Anstaett and Emily J. Greb - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Jan 7, 2019 | 18 | Redacted Document (30) Docket Text: REDACTED VERSION of [13] Amended Complaint, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jan 7, 2019 | 19 | Text of Proposed Order (1) |
| Jan 7, 2019 | 20 | Memorandum in Opposition to Motion (23) Docket Text: OPENING BRIEF in Support re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 1/22/2019. (Cottrell, Frederick) Modified on 10/11/2019 (nmf). [Transferred from Delaware on 11/4/2019.] |
| Jan 7, 2019 | 21 | Other Document (7) |
| Jan 7, 2019 | 21 | Exhibit 1-3 (213) |
| Jan 7, 2019 | 22 | Corporate Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan N.V. for Mylan Inc.; Corporate Parent Mylan Inc. for Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Jan 7, 2019 | 19 | Main Document (2) Docket Text: MOTION to Dismiss for Failure to State a Claim and Improper Venue - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Cottrell, Frederick)[Transferred from Delaware on 11/4/2019.] |
| Jan 7, 2019 | 21 | Main Document (7) Docket Text: DECLARATION re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [20] Opening Brief in Support, (Declaration of Keith Meckstroth) by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-3)(Cottrell, Frederick) Modified on 10/11/2019 (nmf). [Transferred from Delaware on 11/4/2019.] |
| Jan 4, 2019 | 17 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. 3M Company served on 1/3/2019, answer due 1/24/2019. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Jan 3, 2019 | N/A | * (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to 3M Company. (sar) [Transferred from Delaware on 11/4/2019.] |
| Jan 2, 2019 | N/A | Order on Motion for Leave to Appear (0) |
| Dec 31, 2018 | 16 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to Plaintiffs' First Amended Complaint to January 7, 2019 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Dec 27, 2018 | N/A | Order on Motion for Leave to Appear (0) |
| Dec 26, 2018 | 15 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME Regarding Extension of Time to File Redactions to the First Amended Complaint to January 4, 2019 - filed by 3M Company, Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra)[Transferred from Delaware on 11/4/2019.] |
| Dec 20, 2018 | N/A | * (0) |
| Dec 20, 2018 | 14 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. 3M Company served on 12/20/2018, answer due 1/10/2019. (Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Nov 27, 2018 | N/A | Add and Terminate Attorneys (0) |
| Nov 27, 2018 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc. (Cottrell, Frederick) [Transferred from Delaware on 11/4/2019.] |
| Nov 16, 2018 | N/A | Order on Motion for Leave to Appear (0) |
| Nov 15, 2018 | N/A | Order on Motion for Leave to Appear (0) |
| Nov 15, 2018 | 11 | Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna (4) |
| Nov 15, 2018 | 11 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Nov 14, 2018 | 10 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to Plaintiffs' Complaint to December 20, 2018 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Rawnsley, Jason)[Transferred from Delaware on 11/4/2019.] |
| Nov 2, 2018 | N/A | Order on Motion for Leave to Appear (0) |
| Nov 1, 2018 | 9 | Motion for Extension of Time to File (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to November 14, 2018 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) [Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2018 | 7 | Other Document (2) |
| Oct 18, 2018 | 7 | Exhibit A & B (5) |
| Oct 18, 2018 | 8 | Other Document (2) |
| Oct 18, 2018 | 8 | Exhibit A & B (6) |
| Oct 18, 2018 | 7 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Mylan Pharmaceuticals Inc. made on October 17, 2018 by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A & B)(Silver, Daniel)[Transferred from Delaware on 11/4/2019.] |
| Oct 18, 2018 | 8 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Mylan Inc. made on October 11, 2018 by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A & B)(Silver, Daniel) [Transferred from Delaware on 11/4/2019.] |
| Oct 17, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | N/A | * (0) |
| Oct 11, 2018 | 1 | Complaint (39) |
| Oct 11, 2018 | 1 | Exhibits A-D (85) |
| Oct 11, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 11, 2018 | 2 | Other Document (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | 3 | Other Document (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/30/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 3/1/2021. (ceg)[Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | 4 | Report Re: Patent/Trademark (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328; 8,143,239; 8,575,137; 7,967,011. (ceg) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | 5 | Corporate Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (ceg) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | 6 | Corporate Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (ceg) [Transferred from Delaware on 11/4/2019.] |
| Oct 11, 2018 | 1 | Main Document (39) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2479128.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibits A-D, # (2) Civil Cover Sheet)(ceg) [Transferred from Delaware on 11/4/2019.] |
